Synthetic biologists have developed a flexible new platform that solves part of this daunting delivery problem. Mimicking natural processes used by viruses, the delivery system binds to target cells and effectively transfers drugs inside.
A groundbreaking study sheds new light on the evolution of the coronavirus and its variants of concern by analyzing the behavior of atoms in the proteins at the interface between the virus and humans.
Ultrasmall fluorescent core-shell hybrid silica nanoparticles are among the nanocarriers for therapeutics that were thought to be viable only by injection, but new research has shown the potential for their oral administration.
CRISPR enhanced optothermal nanotweezers represent a technological breakthrough, offering unparalleled precision in DNA targeting and detection, transforming the landscape of genetic analysis and biosensing.
